Access to anti-retroviral drugs, female in Nepal
Nepal: Access to anti-retroviral drugs, female was 83.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Nepal, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Nepal stood at 83.0%. That is the highest value across all 25 years on record.
That represents a change of up 6.4% on the previous year and up 159.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Nepal peaked at 83.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Nepal 53rd out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Nepal, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 2.0% | +100.0% |
| 2007 | 5.0% | +150.0% |
| 2008 | 9.0% | +80.0% |
| 2009 | 11.0% | +22.2% |
| 2010 | 15.0% | +36.4% |
| 2011 | 20.0% | +33.3% |
| 2012 | 24.0% | +20.0% |
| 2013 | 28.0% | +16.7% |
| 2014 | 32.0% | +14.3% |
| 2015 | 37.0% | +15.6% |
| 2016 | 40.0% | +8.1% |
| 2017 | 48.0% | +20.0% |
| 2018 | 53.0% | +10.4% |
| 2019 | 58.0% | +9.4% |
| 2020 | 62.0% | +6.9% |
| 2021 | 68.0% | +9.7% |
| 2022 | 73.0% | +7.4% |
| 2023 | 78.0% | +6.8% |
| 2024 | 83.0% | +6.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.8% | 0.0% | 11.0% | 10 |
| 2010s | 35.5% | 15.0% | 58.0% | 10 |
| 2020s | 72.8% | 62.0% | 83.0% | 5 |
Countries ranked near Nepal
More gender data for Nepal
- Child population (UN estimates and projections) 7,927 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7039 % change on previous year (2030)
- Population 22,583 (2030)
- Working-age population (UN estimates and projections) 22,583 (2030)
- Population (UN estimates and projections), annual growth rate 1.5 % change on previous year (2030)
- Age population, age 00, female, interpolated 264,089 (2025)
- Age population, age 00, male, interpolated 273,367 (2025)
- Age population, age 01, female, interpolated 265,882 (2025)
- Age population, age 01, male, interpolated 274,092 (2025)
- Age population, age 02, female, interpolated 268,570 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Nepal?
- Access to anti-retroviral drugs, female in Nepal was 83.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Nepal?
- The highest recorded value was 83.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Nepal?
- The lowest recorded value was 0.0% in 2000.
- How does Nepal rank for access to anti-retroviral drugs, female?
- Nepal ranks 53rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Nepal?
- Over the last ten years it is up 159.4%. The long-run trend across the full record is volatile.
- Where does this Nepal data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.